Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02624193 · ClinicalTrials.gov registry record · NA

Health Improvement for Baltimore Youth

A NA study of HIV and Medication Adherence, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
97
Enrollment target
2
Study locations

NCT02624193 is a NA study of HIV and Medication Adherence that has completed, run by Johns Hopkins University. The registered enrollment target is 97 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02624193, a NA study of HIV and Medication Adherence, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target
2
Study locations

Study Summary

Preliminary data from the investigators' National Center for Complementary and Alternative Medicine (NCCAM)-funded R21 on mindfulness-based stress reduction (MBSR) in HIV-infected youth suggest an association between mindfulness and improved self-regulation and medication adherence. This randomized, controlled trial will help the investigators to better understand the specific impact of MBSR on HIV medication and treatment adherence in HIV-infected youth, and the efficacy of MBSR in the amelioration of stress and improved self-regulation.

Interventions

  • BEHAVIORAL MBSR Program
  • BEHAVIORAL HT Program

Study Locations (2)

Maryland

  • University of Maryland Medical Center - Baltimore
  • Johns Hopkins Harriet Lane Clinic - Baltimore

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2013-04
Est. Completion 2018-06-25
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT02624193

The ClinicalTrials.gov registry entry for NCT02624193 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (78% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which MBSR Program is the first listed.

NCT02624193 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02624193 about?

NCT02624193 is a clinical study titled "Health Improvement for Baltimore Youth". Preliminary data from the investigators' National Center for Complementary and Alternative Medicine (NCCAM)-funded R21 on mindfulness-based stress reduction (MBSR) in HIV-infected youth suggest an association between mindfulness and improved self-regulation and medication adherence. This randomized,...

What is the current status of trial NCT02624193?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2013-04. Estimated completion is 2018-06-25.

What conditions does trial NCT02624193 study?

This clinical trial studies the following conditions: HIV, Medication Adherence, Adolescent Behavior, Adolescent Development.

What interventions are being tested in trial NCT02624193?

The interventions under investigation include: MBSR Program (BEHAVIORAL), HT Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02624193?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02624193 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.